Several factors contribute to the limited scalability of cancer treatments:
High Costs: Advanced therapies often involve expensive research, development, and production processes, making them prohibitively expensive for widespread use. Complex Manufacturing: Some treatments, like CAR-T cell therapy, require intricate and personalized manufacturing processes that are difficult to scale up. Regulatory Hurdles: Navigating the regulatory landscape for new treatments can be time-consuming and costly, delaying broader availability. Infrastructure Limitations: Adequate healthcare infrastructure is essential for delivering advanced cancer treatments, which may not be available in all areas.
